[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:map2k4-wt-allele":3},{"name":4,"total":5,"recruiting":6,"trials":7},"MAP2K4 wt Allele",1,0,[8],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07612007","HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization",[12],"Phase 2","NOT_YET_RECRUITING","2026-08-26T02:19:06.150683Z","2026-07-05T05:32:16.643022Z"]